| Title | Author(s) | Issue date | ???itemlist.??? |
| The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasms | Hatzimichael, E.; Dasoula, A.; Benetatos, L.; Makis, A.; Stebbing, J.; Crook, T.; Syrrou, M.; Bourantas, K. L. | 24-Nov-2015 | - |
| Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia | Hatzimichael, E.; Benetatos, L.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Georgiou, I.; Syrrou, M.; Stebbing, J.; Coley, H. M.; Crook, T.; Bourantas, K. L. | 24-Nov-2015 | - |
| Absence of mutations of the EPO-receptor gene in Greek patients with familial polycythemia | Bourantas, L. K.; Chatzikyriakidou, A.; Dasoula, A.; Syrrou, M.; Bournatas, K. L.; Georgiou, I. | 24-Nov-2015 | - |
| Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease | Voutsinas, G. E.; Stavrou, E. F.; Karousos, G.; Dasoula, A.; Papachatzopoulou, A.; Syrrou, M.; Verkerk, A. J.; van der Spek, P.; Patrinos, G. P.; Stoger, R.; Athanassiadou, A. | 24-Nov-2015 | - |
| Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implications | Hatzimichael, E.; Dasoula, A.; Kounnis, V.; Benetatos, L.; Nigro, C. L.; Lattanzio, L.; Papoudou-Bai, A.; Dranitsaris, G.; Briasoulis, E.; Crook, T. | 24-Nov-2015 | - |
| CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes | Benetatos, L.; Hatzimichael, E.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Syrrou, M.; Georgiou, I.; Bourantas, K. L. | 24-Nov-2015 | - |
| Jun B Expression Is Associated with Non-GC (Germinal Center) B Cell Differentiation Immunophenotype, and Jun B and Jun D with High Proliferation of Tumor Cells in DLBCL. | Papoudou-Bai, A.; Batistatou, A.; Hatzimichael, E.; Dasoula, A.; Kanavaros, P.; Malamou-Mitsi, V. | 24-Nov-2015 | - |
| Methylation analysis of the von Hippel-Lindau gene in acute myeloid leukaemia and myelodysplastic syndromes | Benetatos, L.; Dasoula, A.; Syed, N.; Hatzimichael, E.; Crook, T.; Bourantas, K. L. | 24-Nov-2015 | - |
| Methylation status of the SNRPN and HUMARA genes in testicular biopsy samples | Dasoula, A.; Georgiou, I.; Kontogianni, E.; Sofikitis, N.; Syrrou, M. | 24-Nov-2015 | - |
| Mosaic trisomy r(14) associated with epilepsy and mental retardation | Tzoufi, M.; Kanioglou, C.; Dasoula, A.; Asproudis, I.; Tsatsoulis, A.; Sismani, C.; Patsalis, P. C.; Georgiou, I.; Syrrou, M. | 24-Nov-2015 | - |
| Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions | Benetatos, L.; Dasoula, A.; Hatzimichael, E.; Syed, N.; Voukelatou, M.; Dranitsaris, G.; Bourantas, K. L.; Crook, T. | 24-Nov-2015 | - |
| The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia | Hatzimichael, E.; Dasoula, A.; Shah, R.; Syed, N.; Papoudou-Bai, A.; Coley, H. M.; Dranitsaris, G.; Bourantas, K. L.; Stebbing, J.; Crook, T. | 24-Nov-2015 | - |
| Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma | Benetatos, L.; Dasoula, A.; Hatzimichael, E.; Georgiou, I.; Syrrou, M.; Bourantas, K. L. | 24-Nov-2015 | - |
| Skewed X-chromosome inactivation in Greek women with idiopathic recurrent miscarriage | Dasoula, A.; Kalantaridou, S.; Sotiriadis, A.; Pavlou, M.; Georgiou, I.; Paraskevaidis, E.; Makrigiannakis, A.; Syrrou, M. | 24-Nov-2015 | - |
| Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone disease | Hatzimichael, E.; Dranitsaris, G.; Dasoula, A.; Benetatos, L.; Stebbing, J.; Crook, T.; Bourantas, K. L. | 24-Nov-2015 | - |
